ArticleCancer drug resistance (Alhambra, Calif.)2020

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer.

William W Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.